Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia.
Purity:
>98.5%
CAS Number:
[853426-35-4]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted